ORXOF
Price:
$1.08
Market Cap:
$410.47M
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microv...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-04-11
Stock Exchange
PNK
Ticker
ORXOF
According to Orexo AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 876.57M. This represents a change of 0.73% compared to the average of 870.20M of the last 4 quarters.
The mean historical Enterprise Value of Orexo AB (publ) over the last ten years is 1.61B. The current 876.57M Enterprise Value has changed 5.35% with respect to the historical average. Over the past ten years (40 quarters), ORXOF's Enterprise Value was at its highest in in the March 2015 quarter at 5.08B. The Enterprise Value was at its lowest in in the June 2023 quarter at 651.91M.
Average
1.61B
Median
1.30B
Minimum
715.01M
Maximum
4.44B
Discovering the peaks and valleys of Orexo AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 74.72%
Maximum Annual Enterprise Value = 4.44B
Minimum Annual Increase = -51.97%
Minimum Annual Enterprise Value = 715.01M
Year | Enterprise Value | Change |
---|---|---|
2023 | 715.01M | -29.56% |
2022 | 1.02B | -21.60% |
2021 | 1.29B | -14.26% |
2020 | 1.51B | -7.67% |
2019 | 1.64B | 74.72% |
2018 | 936.17M | -14.90% |
2017 | 1.10B | -15.78% |
2016 | 1.31B | -38.72% |
2015 | 2.13B | -51.97% |
2014 | 4.44B | -8.64% |
The current Enterprise Value of Orexo AB (publ) (ORXOF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.01B
5-year avg
1.23B
10-year avg
1.61B
Orexo AB (publ)’s Enterprise Value is less than Genomma Lab Internacional, S.A.B. de C.V. (4.74B), less than Hypera S.A. (20.14B), less than Sumitomo Pharma Co., Ltd. (545.27B), less than Indivior PLC (1.39B), less than Elanco Animal Health Incorporated (10.47B), greater than SIGA Technologies, Inc. (363.97M), greater than Esperion Therapeutics, Inc. (620.77M), less than Catalent, Inc. (15.68B),
Company | Enterprise Value | Market cap |
---|---|---|
4.74B | $1.30B | |
20.14B | $2.17B | |
545.27B | $1.51B | |
1.39B | $3.01B | |
10.47B | $6.60B | |
363.97M | $462.70M | |
620.77M | $496.53M | |
15.68B | $11.07B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orexo AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orexo AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Orexo AB (publ)'s Enterprise Value?
What is the highest Enterprise Value for Orexo AB (publ) (ORXOF)?
What is the 3-year average Enterprise Value for Orexo AB (publ) (ORXOF)?
What is the 5-year average Enterprise Value for Orexo AB (publ) (ORXOF)?
How does the current Enterprise Value for Orexo AB (publ) (ORXOF) compare to its historical average?